Synthetic biomarkers are an emerging class of diagnostics that amplify disease signals for sensitive and specific detection of early-stage cancers. This Review discusses the rationale and design of biofluid-based synthetic biomarkers as well as translational challenges and future directions.
- Gabriel A. Kwong
- Sharmistha Ghosh
- Sangeeta N. Bhatia